What is the treatment for urticaria (hives) without pruritus (itching)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Hives Without Itching

The first-line treatment for urticaria (hives) without pruritus (itching) is non-sedating H1-antihistamines such as cetirizine 10 mg, fexofenadine 180 mg, or loratadine 10 mg daily. 1, 2

First-Line Treatments

Non-sedating Antihistamines

  • First choice: Non-sedating H1-antihistamines at standard doses:
    • Cetirizine 10 mg daily
    • Fexofenadine 180 mg daily
    • Loratadine 10 mg daily
    • Desloratadine 5 mg daily

Even without itching, these medications help reduce the inflammatory response causing the hives by blocking histamine receptors 1, 2.

Topical Treatments

  • Moderate to high-potency topical corticosteroids (e.g., mometasone furoate 0.1% or betamethasone valerate 0.1%)
  • Menthol 0.5% preparations for cooling effect
  • Emollients to maintain skin hydration 2

Second-Line Treatments

Dose Escalation

If standard doses are ineffective, guidelines support increasing the dose of second-generation H1-antihistamines up to 4 times the standard dose when benefits outweigh risks 1.

Combination Therapy

  • H1 + H2 antagonist combinations (e.g., fexofenadine with cimetidine) may be more effective than H1 antagonists alone 3
  • Evidence shows that ranitidine combined with diphenhydramine is more effective than diphenhydramine alone (RR 1.59,95% CI 1.07 to 2.36) 3

Third-Line Treatments

Immunomodulatory Agents

For severe or refractory cases:

  • Montelukast (antileukotriene) - may benefit aspirin-sensitive urticaria 1
  • Short courses of oral corticosteroids (e.g., prednisolone 50 mg daily for 3 days) for acute severe episodes 1

Other Systemic Options

  • Doxepin - acts as a potent histamine antagonist in both topical and oral forms 2
  • Mirtazapine - may be helpful for various types of urticaria 2

Special Considerations

Physical Urticaria

  • Physical urticarias (triggered by pressure, cold, heat, etc.) typically have weals lasting less than 1 hour (except delayed pressure urticaria) 1
  • Identify and avoid physical triggers when possible
  • For symptomatic dermatographism, a combination of an antihistamine and an H2 antagonist (e.g., chlorphenamine and cimetidine) appears effective 4

Duration of Treatment

  • For acute urticaria: Short-term treatment (up to 2 weeks) is usually sufficient
  • For chronic urticaria: Intermediate-term treatment (2 weeks to 3 months) may be necessary 5

Monitoring and Follow-up

  • Assess response to treatment after 2-4 weeks
  • If no improvement, consider:
    1. Increasing antihistamine dose
    2. Adding H2 antagonist
    3. Switching to a different antihistamine
    4. Referral to dermatology for consideration of immunomodulatory therapy

Treatment Algorithm

  1. Start with standard dose non-sedating H1-antihistamine
  2. If inadequate response after 2 weeks, increase dose up to 4x standard
  3. If still inadequate, add H2 antagonist or switch antihistamine class
  4. For severe or refractory cases, consider short course of oral corticosteroids
  5. For chronic cases not responding to above measures, consider referral for immunomodulatory therapy

Cautions

  • Sedating antihistamines (hydroxyzine, chlorphenamine) should be avoided in the elderly and those with liver disease due to increased risk of sedation 1
  • Long-term use of sedative antihistamines may predispose patients to dementia 2
  • Antihistamines should be used with caution during pregnancy, especially in the first trimester 1

The evidence suggests that while antihistamines are the mainstay of treatment for urticaria, their effectiveness may vary between individuals, and combination therapy may be necessary for optimal management 5, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Histamine H2-receptor antagonists for urticaria.

The Cochrane database of systematic reviews, 2012

Research

Treatment of urticaria. An evidence-based evaluation of antihistamines.

American journal of clinical dermatology, 2001

Research

H1-antihistamines for chronic spontaneous urticaria.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.